Stephen Hahn, AP

August 27, 2020 06:52 AM EDTUpdated 10:20 AM

FDA commish Hahn spotlights Oct 22 vaccine advisory meeting as the next big flashpoint in the Covid-19 campaign

John Carroll

Editor & Founder

Mark October 22 on your calendars if you want to watch the next big controversy over the rapid-fire development of Covid-19 vaccines play out at …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure

The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease

New CBER chief Prasad is readying 'massive framework' around vaccines, Makary says

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

Exclusive: Drug compounder Empower was built on risky shortcuts, ex-employees and inspections allege

Eli Lilly turns to South Korean RNA editing biotech for hearing loss in deal worth $1.3B